SIRT2 and Parkinson disease: ICL-SIRT078 treatment of a rat dopaminergic neural cell line also attenuated loss of cell viability in induced Parkinson’s disease cell death [121], consistent with prior reports of the benefits of Sirt2 inhibition in Parkinson’s disease [139].